Drug intelligence / Profile preview

myricitrin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Myricitrin** is a naturally occurring glycosyloxyflavone, specifically the 3-O-rhamnoside of myricetin, with molecular formula **C21H20O12** and CAS number **17912-87-7**[2]. It is isolated from plants such as Myrica cerifera and Myrtus communis. Myricitrin exhibits **potent antioxidant** and **radical scavenging** activities, together with reported **antimutagenic** and **anti-allergic** effects[2]. Its biological actions include inhibition of mutagenicity (including inhibition against agents like nifuroxazide, aflatoxin B1, and H2O2) and general cytoprotective effects. Myricitrin is a reference standard in chemical analysis of herbal preparations and is found in several food and medicinal plant extracts[2]. The mechanism of action is primarily through scavenging reactive oxygen species, reducing oxidative stress, and potentially modulating inflammatory responses.

Other names
myricetrincannabiscitrinmiricitirnmyricitrinemetricationmyricitroside
02

Targets

AR (Adrenergic receptors)NOX4 (NADPH oxidase 4)

Beyond the preview

Go deeper on myricitrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myricitrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call